Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group

BACKGROUND: Augmentation therapy (AT) is the only specific treatment licensed for patients with alpha-1 antitrypsin deficiency (AATD) associated lung disease. Since patients with severe AATD may have a very different prognosis and AT requires intravenous infusions for life, the decision to initiate...

Descripción completa

Detalles Bibliográficos
Autores principales: Greulich, Timm, Albert, Anna, Cassel, Werner, Boeselt, Tobias, Peychev, Erika, Klemmer, Andreas, Ferreira, Francini, Clarenbach, Christian, Torres-Duran, Maria L, Turner, Alice M, Miravitlles, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743984/
https://www.ncbi.nlm.nih.gov/pubmed/35023913
http://dx.doi.org/10.2147/COPD.S346051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743984/
https://www.ncbi.nlm.nih.gov/pubmed/35023913
http://dx.doi.org/10.2147/COPD.S346051

Ejemplares similares